Products for Research Use Only
RegisterLogin

4-P-PDOT

CAT: 0804-HY-100609-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-100609-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
4-P-PDOT is a potent, selective and affinity Melatonin receptor (MT2) antagonist. 4-P-PDOT is >300-fold more selective for MT2 than MT1. 4-P-PDOT significantly counteracts Melatonin-mediated antioxidant effects (GSH/GSSG ratio, phospho-ERK, Nrf2 nuclear translocation, Nrf2 DNA-binding activity) [1][2][3][4].
CAS Number
134865-74-0
UNSPSC
12352005
Hazard Statement
H302
Target
Melatonin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/4-p-pdot.html
Purity
99.90
Solubility
DMSO : 41.67 mg/mL (ultrasonic)
Smiles
CCC(NC1CC2=C(C=CC=C2)C(C3=CC=CC=C3)C1)=O
Molecular Formula
C19H21NO
Molecular Weight
279.38
Precautions
H302
References & Citations
[1]Dubocovich ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci. 1995 Feb;16 (2) :50-6.|[2]hin EJ, et al. Melatonin attenuates memory impairment induced by Klotho gene deficiency via interactive signaling between MT2 receptor, ERK, and Nrf2-related antioxidant potential. Int J Neuropsychopharmacol. 2014 Dec 30;18 (6) . pii: pyu105.|[3]Christopher Browning, et al. Pharmacological characterization of human recombinant melatonin mt1 and MT2 receptors. British Journal of Pharmacology (2000) 129, 877-886.|[4]Dubocovich ML, et al. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol. 1997 Mar;355 (3) :365-75.|[5]Roberto Pariente, et al. Participation of MT3 melatonin receptors in the synergistic effect of melatonin on cytotoxic and apoptotic actions evoked by chemotherapeutics. Cancer Chemother Pharmacol. 2017 Nov;80 (5) :985-998.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MT2

Related Products

CatalogName
HY-115608-01Cis-4P-PDOT
HY-101358-018-M-PDOT
HY-101358R8-M-PDOT (Standard)
HY-1703234-TM.P
HY-P10564Pardaxin P 4
HY-161645P-gp modulator-4
HY-P3891Substance P (4-11)
HY-P3598Substance P (1-4)
HY-N142914-Methoxy-p-toluquinone
HY-172324DPPI-4-P (ammonium)

Alternative Products

CatalogName
B6559-54-P-PDOT
GTR19244407-018-M-PDOT

Popular Products